Vor Biopharma (VOR) Current Assets (2020 - 2026)
Vor Biopharma's Current Assets came in at $475.11 million for Q2 2026, up 131.8% from $204.93 million a year earlier but down 5.1% from the prior quarter.
Vor Biopharma (VOR) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Vor Biopharma's Current Assets was $458.11 million, up 374.7% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 56.3% (FY2020 to FY2025).
- Going back by year, Current Assets was $96.51 million in FY2024 (-31.5%), $140.8 million in FY2023 (-40.6%), $236.95 million in FY2022 (+10.5%) and $214.4 million in FY2021 (+336.6%).
- The five-year range for quarterly Current Assets is $64.85 million (Q1 2025) to $500.78 million (Q1 2026).
- Year-over-year, Current Assets has increased for five consecutive quarters, with growth averaging 166.2% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in Q1 2026 (growth of 672.2%), and the weakest in Q3 2024 (a decline of 59.1%).
- Business Quant data shows VOR's Current Assets at $500.78 million (Q1 2026), $458.11 million (Q4 2025) and $172.49 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Vor Biopharma | 992.14 Mn | -591.18 Mn | - | 475.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 475.11 Mn |
| Mar 31, 2026 | 500.78 Mn |
| Dec 31, 2025 | 458.11 Mn |
| Sep 30, 2025 | 172.49 Mn |
| Jun 30, 2025 | 204.93 Mn |
| Mar 31, 2025 | 64.85 Mn |
| Dec 31, 2024 | 96.51 Mn |
| Sep 30, 2024 | 67.30 Mn |
| Jun 30, 2024 | 90.26 Mn |
| Mar 31, 2024 | 111.82 Mn |
| Dec 31, 2023 | 140.80 Mn |
| Sep 30, 2023 | 164.44 Mn |
| Jun 30, 2023 | 191.39 Mn |
| Mar 31, 2023 | 216.90 Mn |
| Dec 31, 2022 | 236.95 Mn |
| Sep 30, 2022 | 142.73 Mn |
| Jun 30, 2022 | 158.84 Mn |
| Mar 31, 2022 | 190.30 Mn |
| Dec 31, 2021 | 214.40 Mn |
| Sep 30, 2021 | 232.07 Mn |
Vor Biopharma Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=VOR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "VOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=VOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();